CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

adult cough and chest congestion

Children Cough and Chest Congestion· ingredient dextromethorphanExpectorants· DEXTROMETHORPHAN HYDROBROMIDE 10 mg/10mL; GUAIFENESIN 100 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 200 mg/20mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.01973
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other dextromethorphan products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
ACTINEL Diabetic$0.01104−$0.00870
BACTIMICINA COUGH AND COLD$0.02085+$0.00110
7 Select Maximum Strength$0.02142+$0.00170
Adult Cough Relief$0.02292+$0.00320
Promethazine DM$0.03852+$0.01880
AMAZON Childrens Multi Symptom Cold$0.04678+$0.02710
12 HR RELIEF COUGH DM$0.06804+$0.04830
VANACOF DM$0.06956+$0.04980

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.